Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Ravi

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Cancers|May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal TumorsRyan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell TumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Oncotarget|April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomasRoman Groisberg, David S Hong, Vijaykumar Holla, et al.
American Journal of Clinical Oncology|December 4, 2025
Primary Synovial Sarcoma of the Abdomen and PelvisRiddhi R Patel, Jonathan Feit, Grace Werling, et al.
Future Oncology (London, England)|December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
American Journal of Clinical Oncology|September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors|August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohortMichael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Cancers|March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Clinical Sarcoma Research|January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapyWei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Cancers|May 11, 2024
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal TumorsRyan A Denu, Cissimol P Joseph, Elizabeth S Urquiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell TumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Oncotarget|April 21, 2017
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomasRoman Groisberg, David S Hong, Vijaykumar Holla, et al.
American Journal of Clinical Oncology|December 4, 2025
Primary Synovial Sarcoma of the Abdomen and PelvisRiddhi R Patel, Jonathan Feit, Grace Werling, et al.
Future Oncology (London, England)|December 22, 2025
A plain language summary of the AMPECT study: nab-sirolimus for advanced malignant perivascular epithelioid cell tumorsAndrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.
American Journal of Clinical Oncology|September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors|August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohortMichael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Cancers|March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Clinical Sarcoma Research|January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapyWei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Pageof 11